Effects of vilazodone on sexual functioning in healthy adults: results from a randomized, double-blind, placebo-controlled, and active-controlled study

Clayton, Anita H.; Durgam, Suresh; Li, Dayong; More

International Clinical Psychopharmacology . 32(1):27-35, January 2017.

Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled...

Sambunaris, Angelo; Gommoll, Carl; Chen, Changzheng; More

International Clinical Psychopharmacology . 29(4):197-205, July 2014.

Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study

Jacobsen, Paula L.; Harper, Linda; Chrones, Lambros; More

International Clinical Psychopharmacology . 30(5):255-264, September 2015.

Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study

Alam, Mohammed Y.; Jacobsen, Paula L.; Chen, Yinzhong; More

International Clinical Psychopharmacology . 29(1):36-44, January 2014.

Changes in prolactin levels and sexual function in young psychotic patients after switching from long-acting injectable risperidone to paliperidone palmitate

Montalvo, Itziar; Ortega, Laura; López, Xavi; More

International Clinical Psychopharmacology . 28(1):46-49, January 2013.

The efficacy of extended-release levomilnacipran in moderate to severe major depressive disorder: secondary and post-hoc analyses from a randomized, double-blind,...

Montgomery, Stuart A.; Mansuy, Lucilla; Ruth, Adam C.; More

International Clinical Psychopharmacology . 29(1):26-35, January 2014.

Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?

Benatti, Beatrice; Camuri, Giulia; Dell’Osso, Bernardo; More

International Clinical Psychopharmacology . 31(6):347-352, November 2016.

Antidepressant efficacy of agomelatine versus SSRI/SNRI: results from a pooled analysis of head-to-head studies without a placebo control

Kasper, Siegfried; Corruble, Emmanuelle; Hale, Anthony; More

International Clinical Psychopharmacology . 28(1):12-19, January 2013.

Is it time to shift to better characterization of patients in trials assessing novel antidepressants? An example of two relapse prevention studies with agomelatine

Goodwin, Guy M.; Boyer, Patrice; Emsley, Robin; More

International Clinical Psychopharmacology . 28(1):20-28, January 2013.

A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release and a long-term extension study for patients with major...

Higuchi, Teruhiko; Kamijima, Kunitoshi; Nakagome, Kazuyuki; More

International Clinical Psychopharmacology . 31(1):8-19, January 2016.